Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 214.60 billion. The enterprise value is 297.96 billion.

Market Cap	214.60B
Enterprise Value	297.96B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 34.23% in one year.

Current Share Class	77.75M
Shares Outstanding	77.75M
Shares Change (YoY)	+34.23%
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	20.30%
Owned by Institutions (%)	0.14%
Float	27.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.15
PB Ratio	1.88
P/TBV Ratio	1.91
P/FCF Ratio	n/a
P/OCF Ratio	74.77
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.55
EV / Sales	15.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-62.33

Financial Position

The company has a current ratio of 0.32, with a Debt / Equity ratio of 0.74.

Current Ratio	0.32
Quick Ratio	0.06
Debt / Equity	0.74
Debt / EBITDA	n/a
Debt / FCF	-17.56
Interest Coverage	-4.92

Financial Efficiency

Return on equity (ROE) is -22.14% and return on invested capital (ROIC) is -10.15%.

Return on Equity (ROE)	-22.14%
Return on Assets (ROA)	-7.76%
Return on Invested Capital (ROIC)	-10.15%
Return on Capital Employed (ROCE)	-24.64%
Weighted Average Cost of Capital (WACC)	8.02%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.07
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.46% in the last 52 weeks. The beta is 0.78, so KOSDAQ:334970's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-38.46%
50-Day Moving Average	3,010.20
200-Day Moving Average	3,436.35
Relative Strength Index (RSI)	36.70
Average Volume (20 Days)	161,155

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 19.24 billion and -28.23 billion in losses. Loss per share was -344.02.

Revenue	19.24B
Gross Profit	-10.19B
Operating Income	-34.80B
Pretax Income	-28.23B
Net Income	-28.23B
EBITDA	-20.39B
EBIT	-34.80B
Loss Per Share	-344.02

Balance Sheet

The company has 563.06 million in cash and 83.93 billion in debt, with a net cash position of -83.36 billion or -1,072.16 per share.

Cash & Cash Equivalents	563.06M
Total Debt	83.93B
Net Cash	-83.36B
Net Cash Per Share	-1,072.16
Equity (Book Value)	113.99B
Book Value Per Share	1,472.53
Working Capital	-86.84B

Cash Flow

In the last 12 months, operating cash flow was 2.87 billion and capital expenditures -7.65 billion, giving a free cash flow of -4.78 billion.

Operating Cash Flow	2.87B
Capital Expenditures	-7.65B
Free Cash Flow	-4.78B
FCF Per Share	-61.48

Margins

Gross margin is -52.95%, with operating and profit margins of -180.87% and -146.75%.

Gross Margin	-52.95%
Operating Margin	-180.87%
Pretax Margin	-146.75%
Profit Margin	-146.75%
EBITDA Margin	-105.96%
EBIT Margin	-180.87%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.23%
Shareholder Yield	-34.23%
Earnings Yield	-13.16%
FCF Yield	-2.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -0.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.98
Piotroski F-Score	4